About |
Genesis Molecular Technologies, Inc. is a longevity science company focused on the discovery and development of next generation technologies designed to enhance health span, tissue regeneration and healthy aging. The company's innovation platform is built around it's proprietary, patented, CBP/beta catenin antagonist technology, BETASTEM6. This molecule is a novel, patented Skin Longevity Molecule engineered to support the body's natural regenerative processes through the selective modulation of Wnt/Beta catenin signaling. By promoting asymmetric stem cell division and cellular renewal pathways, BetaSTEM6 has demonstrated the ability to enhance skin regeneration, support extracellular matrix remodeling, inhibit collagen degradation, stimulate collagen and glycosaminoglycan (GAG) synthesis, and improve overall skin health and appearance. Through its unique mechanism of action, BetaSTEM6 represents a new approach to addressing the biological markers of skin aging and longevity.